{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T16:21:42Z","timestamp":1794932502599,"version":"4.9.1"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T00:00:00Z","timestamp":1704240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic sclerosis (SSc) is a devastating autoimmune disease characterized by excessive production and accumulation of extracellular matrix, leading to fibrosis of skin and other internal organs. However, the main cellular participants in SSc skin fibrosis remain incompletely understood. Here using differentiation trajectories at a single cell level, we demonstrate a dual source of extracellular matrix deposition in SSc skin from both myofibroblasts and endothelial-to-mesenchymal-transitioning cells (EndoMT). We further define a central role of Hippo pathway effectors in differentiation and homeostasis of myofibroblast and EndoMT, respectively, and show that myofibroblasts and EndoMTs function as central communication hubs that drive key pro-fibrotic signaling pathways in SSc. Together, our data help characterize myofibroblast differentiation and EndoMT phenotypes in SSc skin, and hint that modulation of the Hippo pathway may contribute in reversing the pro-fibrotic phenotypes in myofibroblasts and EndoMTs.<\/jats:p>","DOI":"10.1038\/s41467-023-44645-6","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T07:02:23Z","timestamp":1704265343000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":96,"title":["Systems-based identification of the Hippo pathway for promoting fibrotic mesenchymal differentiation in systemic sclerosis"],"prefix":"10.1038","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6260-0787","authenticated-orcid":false,"given":"Feiyang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Suen","family":"Tsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Gharaee-Kermani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olesya","family":"Plazyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianying","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Kirma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3544-3023","authenticated-orcid":false,"given":"Rachael","family":"Wasikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Hile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0802-2883","authenticated-orcid":false,"given":"Paul W.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9358-9368","authenticated-orcid":false,"given":"Enze","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Ochocki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9905-875X","authenticated-orcid":false,"given":"Shiv","family":"Pillai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanual","family":"Maverakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9355-9564","authenticated-orcid":false,"given":"Matteo","family":"Pellegrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-031X","authenticated-orcid":false,"given":"Robert L.","family":"Modlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lam C.","family":"Tsoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9398-5034","authenticated-orcid":false,"given":"Robert","family":"Lafyatis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4006-8945","authenticated-orcid":false,"given":"J. Michelle","family":"Kahlenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7115-9113","authenticated-orcid":false,"given":"Allison C.","family":"Billi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1412-4453","authenticated-orcid":false,"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0080-0812","authenticated-orcid":false,"given":"Johann E.","family":"Gudjonsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,3]]},"reference":[{"key":"44645_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.chest.2017.06.009","volume":"152","author":"J Morisset","year":"2017","unstructured":"Morisset, J. et al. Mortality risk prediction in scleroderma-related interstitial lung disease: the SADL model. Chest 152, 999\u20131007 (2017).","journal-title":"Chest"},{"key":"44645_CR2","doi-asserted-by":"publisher","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","volume":"1","author":"Y Allanore","year":"2015","unstructured":"Allanore, Y. et al. Systemic sclerosis. Nat. Rev. Dis. Prim. 1, 15002 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"44645_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12760-y","volume":"10","author":"E L\u00f3pez-Isac","year":"2019","unstructured":"L\u00f3pez-Isac, E. et al. GWAS for systemic sclerosis identifies multiple risk loci and highlights fibrotic and vasculopathy pathways. Nat. Commun. 10, 4955 (2019).","journal-title":"Nat. Commun."},{"key":"44645_CR4","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1097\/BOR.0000000000000564","volume":"31","author":"AC Billi","year":"2019","unstructured":"Billi, A. C., Kahlenberg, J. M. & Gudjonsson, J. E. Sex bias in autoimmunity. Curr. Opin. Rheumatol. 31, 53\u201361 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"44645_CR5","doi-asserted-by":"publisher","first-page":"596","DOI":"10.26444\/aaem\/75894","volume":"25","author":"I Walecka","year":"2018","unstructured":"Walecka, I., Roszkiewicz, M. & Malewska, A. Potential occupational and environmental factors in SSc onset. Ann. Agric Environ. Med. 25, 596\u2013601 (2018).","journal-title":"Ann. Agric Environ. Med."},{"key":"44645_CR6","first-page":"1197","volume":"63","author":"S Kalra","year":"2013","unstructured":"Kalra, S. Paediatric diabetes. J. Pak. Med. Assoc. 63, 1197\u20131200 (2013).","journal-title":"J. Pak. Med. Assoc."},{"key":"44645_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano, Y. & Sato, S. Vasculopathy in scleroderma. Semin. Immunopathol. 37, 489\u2013500 (2015).","journal-title":"Semin. Immunopathol."},{"key":"44645_CR8","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1172\/JCI131700","volume":"130","author":"T Maehara","year":"2020","unstructured":"Maehara, T. et al. Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis. J. Clin. Invest. 130, 2451\u20132464 (2020).","journal-title":"J. Clin. Invest."},{"key":"44645_CR9","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga, J. & Abraham, D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J. Clin. Invest. 117, 557\u2013567 (2007).","journal-title":"J. Clin. Invest."},{"key":"44645_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24607-6","volume":"12","author":"T Tabib","year":"2021","unstructured":"Tabib, T. et al. Myofibroblast transcriptome indicates SFRP2(hi) fibroblast progenitors in systemic sclerosis skin. Nat. Commun. 12, 4384 (2021).","journal-title":"Nat. Commun."},{"key":"44645_CR11","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1002\/path.1711660307","volume":"166","author":"RJ Prescott","year":"1992","unstructured":"Prescott, R. J., Freemont, A. J., Jones, C. J., Hoyland, J. & Fielding, P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J. Pathol. 166, 255\u2013263 (1992).","journal-title":"J. Pathol."},{"key":"44645_CR12","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1093\/rheumatology\/kew003","volume":"55","author":"J Ziemek","year":"2016","unstructured":"Ziemek, J. et al. The relationship between skin symptoms and the scleroderma modification of the health assessment questionnaire, the modified Rodnan skin score, and skin pathology in patients with systemic sclerosis. Rheumatology (Oxford) 55, 911\u2013917 (2016).","journal-title":"Rheumatology (Oxford)"},{"key":"44645_CR13","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1016\/j.ajpath.2012.02.004","volume":"180","author":"B Hinz","year":"2012","unstructured":"Hinz, B. et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am. J. Pathol. 180, 1340\u20131355 (2012).","journal-title":"Am. J. Pathol."},{"key":"44645_CR14","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/sj.jid.5700613","volume":"127","author":"B Hinz","year":"2007","unstructured":"Hinz, B. Formation and function of the myofibroblast during tissue repair. J. Invest Dermatol. 127, 526\u2013537 (2007).","journal-title":"J. Invest Dermatol."},{"key":"44645_CR15","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.2353\/ajpath.2007.070112","volume":"170","author":"B Hinz","year":"2007","unstructured":"Hinz, B. et al. The myofibroblast: one function, multiple origins. Am. J. Pathol. 170, 1807\u20131816 (2007).","journal-title":"Am. J. Pathol."},{"key":"44645_CR16","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1002\/art.22186","volume":"54","author":"EY Kissin","year":"2006","unstructured":"Kissin, E. Y., Merkel, P. A. & Lafyatis, R. Myofibroblasts and hyalinized collagen as markers of skin disease in systemic sclerosis. Arthritis Rheum. 54, 3655\u20133660 (2006).","journal-title":"Arthritis Rheum."},{"key":"44645_CR17","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/nrm809","volume":"3","author":"JJ Tomasek","year":"2002","unstructured":"Tomasek, J. J., Gabbiani, G., Hinz, B., Chaponnier, C. & Brown, R. A. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat. Rev. Mol. Cell Biol. 3, 349\u2013363 (2002).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"44645_CR18","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/rheumatology\/kes234","volume":"51","author":"X Shi-wen","year":"2012","unstructured":"Shi-wen, X. et al. Focal adhesion kinase and reactive oxygen species contribute to the persistent fibrotic phenotype of lesional scleroderma fibroblasts. Rheumatology (Oxford) 51, 2146\u20132154 (2012).","journal-title":"Rheumatology (Oxford)"},{"key":"44645_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.matbio.2015.05.006","volume":"47","author":"B Hinz","year":"2015","unstructured":"Hinz, B. The extracellular matrix and transforming growth factor-\u03b21: tale of a strained relationship. Matrix Biol. 47, 54\u201365 (2015).","journal-title":"Matrix Biol."},{"key":"44645_CR20","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1111\/wrr.12950","volume":"29","author":"M Sawant","year":"2021","unstructured":"Sawant, M. et al. A story of fibers and stress: matrix-embedded signals for fibroblast activation in the skin. Wound Repair Regen. 29, 515\u2013530 (2021).","journal-title":"Wound Repair Regen."},{"key":"44645_CR21","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/art.40377","volume":"70","author":"Y Allanore","year":"2018","unstructured":"Allanore, Y., Distler, O., Matucci-Cerinic, M. & Denton, C. P. Review: defining a unified vascular phenotype in systemic sclerosis. Arthritis Rheumatol. 70, 162\u2013170 (2018).","journal-title":"Arthritis Rheumatol."},{"key":"44645_CR22","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1083\/jcb.200704042","volume":"179","author":"PJ Wipff","year":"2007","unstructured":"Wipff, P. J., Rifkin, D. B., Meister, J. J. & Hinz, B. Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix. J. Cell Biol. 179, 1311\u20131323 (2007).","journal-title":"J. Cell Biol."},{"key":"44645_CR23","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1083\/jcb.201402006","volume":"207","author":"F Klingberg","year":"2014","unstructured":"Klingberg, F. et al. Prestress in the extracellular matrix sensitizes latent TGF-\u03b21 for activation. J. Cell Biol. 207, 283\u2013297 (2014).","journal-title":"J. Cell Biol."},{"key":"44645_CR24","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3389\/fimmu.2015.00272","volume":"6","author":"D Pattanaik","year":"2015","unstructured":"Pattanaik, D., Brown, M., Postlethwaite, B. C. & Postlethwaite, A. E. Pathogenesis of systemic sclerosis. Front Immunol. 6, 272 (2015).","journal-title":"Front Immunol."},{"key":"44645_CR25","first-page":"471","volume":"21","author":"P Di Benedetto","year":"2019","unstructured":"Di Benedetto, P., Ruscitti, P., Liakouli, V., Cipriani, P. & Giacomelli, R. The vessels contribute to fibrosis in systemic sclerosis. Isr. Med. Assoc. J. 21, 471\u2013474 (2019).","journal-title":"Isr. Med. Assoc. J."},{"key":"44645_CR26","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1002\/art.37988","volume":"65","author":"M Matucci-Cerinic","year":"2013","unstructured":"Matucci-Cerinic, M., Kahaleh, B. & Wigley, F. M. Review: evidence that systemic sclerosis is a vascular disease. Arthritis Rheum. 65, 1953\u20131962 (2013).","journal-title":"Arthritis Rheum."},{"key":"44645_CR27","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1002\/art.38326","volume":"66","author":"M Kuwana","year":"2014","unstructured":"Kuwana, M. & Okazaki, Y. Brief report: impaired in vivo neovascularization capacity of endothelial progenitor cells in patients with systemic sclerosis. Arthritis Rheumatol. 66, 1300\u20131305 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"44645_CR28","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.tcm.2012.05.011","volume":"21","author":"M Manetti","year":"2011","unstructured":"Manetti, M., Guiducci, S., Ibba-Manneschi, L. & Matucci-Cerinic, M. Impaired angiogenesis in systemic sclerosis: the emerging role of the antiangiogenic VEGF(165)b splice variant. Trends Cardiovasc. Med. 21, 204\u2013210 (2011).","journal-title":"Trends Cardiovasc. Med."},{"key":"44645_CR29","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1172\/JCI118851","volume":"98","author":"R Sgonc","year":"1996","unstructured":"Sgonc, R. et al. Endothelial cell apoptosis is a primary pathogenetic event underlying skin lesions in avian and human scleroderma. J. Clin. Invest 98, 785\u2013792 (1996).","journal-title":"J. Clin. Invest"},{"key":"44645_CR30","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.3389\/fimmu.2018.02191","volume":"9","author":"SA Apostolidis","year":"2018","unstructured":"Apostolidis, S. A. et al. Single Cell RNA sequencing identifies HSPG2 and APLNR as markers of endothelial cell injury in systemic sclerosis skin. Front Immunol. 9, 2191 (2018).","journal-title":"Front Immunol."},{"key":"44645_CR31","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.autrev.2016.03.005","volume":"15","author":"O Cabral-Marques","year":"2016","unstructured":"Cabral-Marques, O. & Riemekasten, G. Vascular hypothesis revisited: role of stimulating antibodies against angiotensin and endothelin receptors in the pathogenesis of systemic sclerosis. Autoimmun. Rev. 15, 690\u2013694 (2016).","journal-title":"Autoimmun. Rev."},{"key":"44645_CR32","doi-asserted-by":"publisher","first-page":"835948","DOI":"10.1155\/2013\/835948","volume":"2013","author":"SA Jimenez","year":"2013","unstructured":"Jimenez, S. A. Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol. 2013, 835948 (2013).","journal-title":"ISRN Rheumatol."},{"key":"44645_CR33","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.3899\/jrheum.150088","volume":"42","author":"P Cipriani","year":"2015","unstructured":"Cipriani, P. et al. The endothelial-mesenchymal transition in systemic sclerosis is induced by endothelin-1 and transforming growth factor-\u03b2 and may be blocked by macitentan, a dual endothelin-1 receptor antagonist. J. Rheumatol. 42, 1808\u20131816 (2015).","journal-title":"J. Rheumatol."},{"key":"44645_CR34","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","volume":"76","author":"M Manetti","year":"2017","unstructured":"Manetti, M. et al. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann. Rheum. Dis. 76, 924\u2013934 (2017).","journal-title":"Ann. Rheum. Dis."},{"key":"44645_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cell.2015.10.044","volume":"163","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Zhao, B. & Guan, K. L. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163, 811\u2013828 (2015).","journal-title":"Cell"},{"key":"44645_CR36","doi-asserted-by":"crossref","unstructured":"Figeac, N. et al. VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle. J. Cell Sci. 132, jcs225946 (2019).","DOI":"10.1242\/jcs.225946"},{"key":"44645_CR37","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1146\/annurev-physiol-021014-071733","volume":"77","author":"FX Yu","year":"2015","unstructured":"Yu, F. X., Meng, Z., Plouffe, S. W. & Guan, K. L. Hippo pathway regulation of gastrointestinal tissues. Annu. Rev. Physiol. 77, 201\u2013227 (2015).","journal-title":"Annu. Rev. Physiol."},{"key":"44645_CR38","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1007\/s00296-021-04956-7","volume":"41","author":"RV Karalilova","year":"2021","unstructured":"Karalilova, R. V., Batalov, Z. A., Sapundzhieva, T. L., Matucci-Cerinic, M. & Batalov, A. Z. Tofacitinib in the treatment of skin and musculoskeletal involvement in patients with systemic sclerosis, evaluated by ultrasound. Rheumatol. Int. 41, 1743\u20131753 (2021).","journal-title":"Rheumatol. Int."},{"key":"44645_CR39","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1136\/annrheumdis-2018-213031","volume":"77","author":"CP Denton","year":"2018","unstructured":"Denton, C. P. et al. Therapeutic interleukin-6 blockade reverses transforming growth factor-beta pathway activation in dermal fibroblasts: insights from the faSScinate clinical trial in systemic sclerosis. Ann. Rheum. Dis. 77, 1362\u20131371 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"44645_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.jid.5701101","volume":"128","author":"J Bayle","year":"2008","unstructured":"Bayle, J. et al. Increased expression of Wnt2 and SFRP4 in Tsk mouse skin: role of Wnt signaling in altered dermal fibrillin deposition and systemic sclerosis. J. Invest Dermatol. 128, 871\u2013881 (2008).","journal-title":"J. Invest Dermatol."},{"key":"44645_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/1346-8138.14088","volume":"45","author":"M Hirabayashi","year":"2018","unstructured":"Hirabayashi, M. et al. Possible pro-inflammatory role of heparin-binding epidermal growth factor-like growth factor in the active phase of systemic sclerosis. J. Dermatol. 45, 182\u2013188 (2018).","journal-title":"J. Dermatol."},{"key":"44645_CR42","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/art.30254","volume":"63","author":"C Dees","year":"2011","unstructured":"Dees, C. et al. Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum. 63, 1396\u20131404 (2011).","journal-title":"Arthritis Rheum."},{"key":"44645_CR43","doi-asserted-by":"publisher","first-page":"102547","DOI":"10.1016\/j.jaut.2020.102547","volume":"116","author":"S Kobayashi","year":"2021","unstructured":"Kobayashi, S. et al. Integrated bulk and single-cell RNA-sequencing identified disease-relevant monocytes and a gene network module underlying systemic sclerosis. J. Autoimmun. 116, 102547 (2021).","journal-title":"J. Autoimmun."},{"key":"44645_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24110-y","volume":"12","author":"CC Deng","year":"2021","unstructured":"Deng, C. C. et al. Single-cell RNA-seq reveals fibroblast heterogeneity and increased mesenchymal fibroblasts in human fibrotic skin diseases. Nat. Commun. 12, 3709 (2021).","journal-title":"Nat. Commun."},{"key":"44645_CR45","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1136\/annrheumdis-2021-220209","volume":"80","author":"AM Gaydosik","year":"2021","unstructured":"Gaydosik, A. M. et al. Single-cell transcriptome analysis identifies skin-specific T-cell responses in systemic sclerosis. Ann. Rheum. Dis. 80, 1453\u20131460 (2021).","journal-title":"Ann. Rheum. Dis."},{"key":"44645_CR46","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.cell.2022.03.011","volume":"185","author":"C Gur","year":"2022","unstructured":"Gur, C. et al. LGR5 expressing skin fibroblasts define a major cellular hub perturbed in scleroderma. Cell 185, 1373\u20131388.e1320 (2022).","journal-title":"Cell"},{"key":"44645_CR47","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/s41590-021-00956-8","volume":"22","author":"F Ma","year":"2021","unstructured":"Ma, F. et al. The cellular architecture of the antimicrobial response network in human leprosy granulomas. Nat. Immunol. 22, 839\u2013850 (2021).","journal-title":"Nat. Immunol."},{"key":"44645_CR48","doi-asserted-by":"publisher","first-page":"eabh1478","DOI":"10.1126\/scitranslmed.abh1478","volume":"14","author":"AM O\u2019Neill","year":"2022","unstructured":"O\u2019Neill, A. M. et al. Antimicrobial production by perifollicular dermal preadipocytes is essential to the pathophysiology of acne. Sci. Transl. Med. 14, eabh1478 (2022).","journal-title":"Sci. Transl. Med."},{"key":"44645_CR49","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1016\/j.jid.2017.09.045","volume":"138","author":"T Tabib","year":"2018","unstructured":"Tabib, T., Morse, C., Wang, T., Chen, W. & Lafyatis, R. SFRP2\/DPP4 and FMO1\/LSP1 define major fibroblast populations in human skin. J. Invest Dermatol. 138, 802\u2013810 (2018).","journal-title":"J. Invest Dermatol."},{"key":"44645_CR50","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.aax0249","volume":"367","author":"GS Gulati","year":"2020","unstructured":"Gulati, G. S. et al. Single-cell transcriptional diversity is a hallmark of developmental potential. Science 367, 405\u2013411 (2020).","journal-title":"Science"},{"key":"44645_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23395-3","volume":"12","author":"N Kastan","year":"2021","unstructured":"Kastan, N. et al. Small-molecule inhibition of Lats kinases may promote Yap-dependent proliferation in postmitotic mammalian tissues. Nat. Commun. 12, 3100 (2021).","journal-title":"Nat. Commun."},{"key":"44645_CR52","doi-asserted-by":"publisher","first-page":"5371","DOI":"10.2147\/OTT.S109979","volume":"9","author":"J Feng","year":"2016","unstructured":"Feng, J. et al. Verteporfin, a suppressor of YAP-TEAD complex, presents promising antitumor properties on ovarian cancer. Onco Targets Ther. 9, 5371\u20135381 (2016).","journal-title":"Onco Targets Ther."},{"key":"44645_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01742-7","volume":"8","author":"JS Fang","year":"2017","unstructured":"Fang, J. S. et al. Shear-induced Notch-Cx37-p27 axis arrests endothelial cell cycle to enable arterial specification. Nat. Commun. 8, 2149 (2017).","journal-title":"Nat. Commun."},{"key":"44645_CR54","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/path.4825","volume":"241","author":"KK Kim","year":"2017","unstructured":"Kim, K. K., Sisson, T. H. & Horowitz, J. C. Fibroblast growth factors and pulmonary fibrosis: it\u2019s more complex than it sounds. J. Pathol. 241, 6\u20139 (2017).","journal-title":"J. Pathol."},{"key":"44645_CR55","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2152\/jmi.60.175","volume":"60","author":"Y Nishioka","year":"2013","unstructured":"Nishioka, Y., Azuma, M., Kishi, M. & Aono, Y. Targeting platelet-derived growth factor as a therapeutic approach in pulmonary fibrosis. J. Med Invest 60, 175\u2013183 (2013).","journal-title":"J. Med Invest"},{"key":"44645_CR56","doi-asserted-by":"publisher","first-page":"v2","DOI":"10.1093\/rheumatology\/ken265","volume":"47","author":"M Trojanowska","year":"2008","unstructured":"Trojanowska, M. Role of PDGF in fibrotic diseases and systemic sclerosis. Rheumatol. (Oxf.) 47, v2\u2013v4 (2008).","journal-title":"Rheumatol. (Oxf.)"},{"key":"44645_CR57","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1053\/j.gastro.2014.01.061","volume":"146","author":"L Yang","year":"2014","unstructured":"Yang, L. et al. Vascular endothelial growth factor promotes fibrosis resolution and repair in mice. Gastroenterology 146, 1339\u20131350.e1331 (2014).","journal-title":"Gastroenterology"},{"key":"44645_CR58","doi-asserted-by":"publisher","first-page":"103745","DOI":"10.1016\/j.ebiom.2021.103745","volume":"74","author":"C Yin","year":"2021","unstructured":"Yin, C. et al. Elevated Wnt2 and Wnt4 activate NF-\u03baB signaling to promote cardiac fibrosis by cooperation of Fzd4\/2 and LRP6 following myocardial infarction. EBioMedicine 74, 103745 (2021).","journal-title":"EBioMedicine"},{"key":"44645_CR59","doi-asserted-by":"publisher","first-page":"5820","DOI":"10.1093\/rheumatology\/keab168","volume":"60","author":"E Adami","year":"2021","unstructured":"Adami, E. et al. IL11 is elevated in systemic sclerosis and IL11-dependent ERK signalling underlies TGF\u03b2-mediated activation of dermal fibroblasts. Rheumatology 60, 5820\u20135826 (2021).","journal-title":"Rheumatology"},{"key":"44645_CR60","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","volume":"16","author":"EH Choy","year":"2020","unstructured":"Choy, E. H. et al. Translating IL-6 biology into effective treatments. Nat. Rev. Rheumatol. 16, 335\u2013345 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"44645_CR61","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1111\/j.1523-1755.2005.00509.x","volume":"68","author":"J Zhang","year":"2005","unstructured":"Zhang, J. & Hill, C. E. Differential connexin expression in preglomerular and postglomerular vasculature: accentuation during diabetes. Kidney Int. 68, 1171\u20131185 (2005).","journal-title":"Kidney Int."},{"key":"44645_CR62","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1681\/ASN.2019080832","volume":"31","author":"SJ Dumas","year":"2020","unstructured":"Dumas, S. J. et al. Single-cell RNA sequencing reveals renal endothelium heterogeneity and metabolic adaptation to water deprivation. J. Am. Soc. Nephrol. 31, 118\u2013138 (2020).","journal-title":"J. Am. Soc. Nephrol."},{"key":"44645_CR63","doi-asserted-by":"publisher","first-page":"e010823","DOI":"10.1161\/JAHA.118.010823","volume":"8","author":"L Le Gal","year":"2019","unstructured":"Le Gal, L. et al. Connexin37-dependent mechanisms selectively contribute to modulate angiotensin II -mediated hypertension. J. Am. Heart Assoc. 8, e010823 (2019).","journal-title":"J. Am. Heart Assoc."},{"key":"44645_CR64","doi-asserted-by":"publisher","first-page":"60","DOI":"10.2329\/perio.42.Supplement2_60","volume":"42","author":"S Hasegawa","year":"2000","unstructured":"Hasegawa, S. et al. [Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis]. Nihon Jinzo Gakkai Shi 42, 60\u201365 (2000).","journal-title":"Nihon Jinzo Gakkai Shi"},{"key":"44645_CR65","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10142-009-0137-8","volume":"10","author":"DA Iacobas","year":"2010","unstructured":"Iacobas, D. A., Iacobas, S., Thomas, N. & Spray, D. C. Sex-dependent gene regulatory networks of the heart rhythm. Funct. Integr. Genom. 10, 73\u201386 (2010).","journal-title":"Funct. Integr. Genom."},{"key":"44645_CR66","doi-asserted-by":"crossref","unstructured":"Laurent, P. et al. Interleukin-1-\u03b2-activated microvascular endothelial cells promote DC-SIGN+ alternative macrophages associated with skin fibrosis in systemic sclerosis. Arthritis Rheumatol 74, 1013\u20131026 (2022).","DOI":"10.1002\/art.42061"},{"key":"44645_CR67","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1146\/annurev-med-041818-011649","volume":"71","author":"SA Cook","year":"2020","unstructured":"Cook, S. A. & Schafer, S. Hiding in plain sight: interleukin-11 emerges as a master regulator of fibrosis, tissue integrity, and stromal inflammation. Annu Rev. Med. 71, 263\u2013276 (2020).","journal-title":"Annu Rev. Med."},{"key":"44645_CR68","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1136\/ard.2009.116434","volume":"69","author":"P Gourh","year":"2010","unstructured":"Gourh, P. et al. Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis. Ann. Rheum. Dis. 69, 550\u2013555 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"44645_CR69","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/jid.2012.389","volume":"133","author":"J Canady","year":"2013","unstructured":"Canady, J., Arndt, S., Karrer, S., Bosserhoff, A. K. & Increased, K. G. F. expression promotes fibroblast activation in a double paracrine manner resulting in cutaneous fibrosis. J. Invest Dermatol. 133, 647\u2013657 (2013).","journal-title":"J. Invest Dermatol."},{"key":"44645_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2174\/1573397114666180809121005","volume":"15","author":"VA Flower","year":"2019","unstructured":"Flower, V. A., Barratt, S. L., Ward, S. & Pauling, J. D. The role of vascular endothelial growth factor in systemic sclerosis. Curr. Rheumatol. Rev. 15, 99\u2013109 (2019).","journal-title":"Curr. Rheumatol. Rev."},{"key":"44645_CR71","doi-asserted-by":"crossref","unstructured":"Tai, Y. et al. Myofibroblasts: function, formation, and scope of molecular therapies for skin fibrosis. Biomolecules 11, 1095 (2021).","DOI":"10.3390\/biom11081095"},{"key":"44645_CR72","doi-asserted-by":"publisher","first-page":"3326","DOI":"10.1016\/j.ajpath.2015.08.011","volume":"185","author":"B Piersma","year":"2015","unstructured":"Piersma, B. et al. YAP1 is a driver of myofibroblast differentiation in normal and diseased fibroblasts. Am. J. Pathol. 185, 3326\u20133337 (2015).","journal-title":"Am. J. Pathol."},{"key":"44645_CR73","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1101\/gad.329763.119","volume":"33","author":"Y Xiao","year":"2019","unstructured":"Xiao, Y. et al. Hippo pathway deletion in adult resting cardiac fibroblasts initiates a cell state transition with spontaneous and self-sustaining fibrosis. Genes Dev. 33, 1491\u20131505 (2019).","journal-title":"Genes Dev."},{"key":"44645_CR74","doi-asserted-by":"crossref","unstructured":"He, X. et al. Myofibroblast YAP\/TAZ activation is a key step in organ fibrogenesis. JCI Insight 7, e146243 (2022).","DOI":"10.1172\/jci.insight.146243"},{"key":"44645_CR75","doi-asserted-by":"publisher","first-page":"3278","DOI":"10.1681\/ASN.2015121354","volume":"28","author":"M Liang","year":"2017","unstructured":"Liang, M. et al. Yap\/Taz Deletion in Gli(+) cell-derived myofibroblasts attenuates fibrosis. J. Am. Soc. Nephrol. 28, 3278\u20133290 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"44645_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12079-020-00596-x","volume":"15","author":"X Shi-Wen","year":"2021","unstructured":"Shi-Wen, X. et al. Verteporfin inhibits the persistent fibrotic phenotype of lesional scleroderma dermal fibroblasts. J. Cell Commun. Signal 15, 71\u201380 (2021).","journal-title":"J. Cell Commun. Signal"},{"key":"44645_CR77","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1101\/gad.1903310","volume":"24","author":"I Lian","year":"2010","unstructured":"Lian, I. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation. Genes Dev. 24, 1106\u20131118 (2010).","journal-title":"Genes Dev."},{"key":"44645_CR78","doi-asserted-by":"publisher","first-page":"e1005465","DOI":"10.1371\/journal.pgen.1005465","volume":"11","author":"C Stein","year":"2015","unstructured":"Stein, C. et al. YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet 11, e1005465 (2015).","journal-title":"PLoS Genet"},{"key":"44645_CR79","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1038\/ncb3216","volume":"17","author":"F Zanconato","year":"2015","unstructured":"Zanconato, F. et al. Genome-wide association between YAP\/TAZ\/TEAD and AP-1 at enhancers drives oncogenic growth. Nat. Cell Biol. 17, 1218\u20131227 (2015).","journal-title":"Nat. Cell Biol."},{"key":"44645_CR80","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cell.2014.06.013","volume":"158","author":"L Azzolin","year":"2014","unstructured":"Azzolin, L. et al. YAP\/TAZ incorporation in the \u03b2-catenin destruction complex orchestrates the Wnt response. Cell 158, 157\u2013170 (2014).","journal-title":"Cell"},{"key":"44645_CR81","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.devcel.2013.01.020","volume":"24","author":"BV Reddy","year":"2013","unstructured":"Reddy, B. V. & Irvine, K. D. Regulation of Hippo signaling by EGFR-MAPK signaling through Ajuba family proteins. Dev. Cell 24, 459\u2013471 (2013).","journal-title":"Dev. Cell"},{"key":"44645_CR82","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.cell.2009.09.035","volume":"139","author":"C Alarc\u00f3n","year":"2009","unstructured":"Alarc\u00f3n, C. et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-beta pathways. Cell 139, 757\u2013769 (2009).","journal-title":"Cell"},{"key":"44645_CR83","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.celrep.2013.11.021","volume":"5","author":"TA Beyer","year":"2013","unstructured":"Beyer, T. A. et al. Switch enhancers interpret TGF-\u03b2 and Hippo signaling to control cell fate in human embryonic stem cells. Cell Rep. 5, 1611\u20131624 (2013).","journal-title":"Cell Rep."},{"key":"44645_CR84","doi-asserted-by":"crossref","unstructured":"Currey, L., Thor, S. & Piper, M. TEAD family transcription factors in development and disease. Development 148, dev196675 (2021).","DOI":"10.1242\/dev.196675"},{"key":"44645_CR85","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3389\/fonc.2020.01266","volume":"10","author":"N Yamaguchi","year":"2020","unstructured":"Yamaguchi, N. Multiple roles of vestigial-like family members in tumor development. Front Oncol. 10, 1266 (2020).","journal-title":"Front Oncol."},{"key":"44645_CR86","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/ni.3643","volume":"18","author":"Y Liang","year":"2017","unstructured":"Liang, Y. et al. A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases. Nat. Immunol. 18, 152\u2013160 (2017).","journal-title":"Nat. Immunol."},{"key":"44645_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36189-6","volume":"14","author":"Y Horii","year":"2023","unstructured":"Horii, Y. et al. VGLL3 is a mechanosensitive protein that promotes cardiac fibrosis through liquid-liquid phase separation. Nat. Commun. 14, 550 (2023).","journal-title":"Nat. Commun."},{"key":"44645_CR88","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/j.semarthrit.2014.11.006","volume":"44","author":"GA Salazar","year":"2015","unstructured":"Salazar, G. A. et al. Antinuclear antibody-negative systemic sclerosis. Semin Arthritis Rheum. 44, 680\u2013686 (2015).","journal-title":"Semin Arthritis Rheum."},{"key":"44645_CR89","doi-asserted-by":"publisher","first-page":"eabn2263","DOI":"10.1126\/scitranslmed.abn2263","volume":"14","author":"AC Billi","year":"2022","unstructured":"Billi, A. C. et al. Nonlesional lupus skin contributes to inflammatory education of myeloid cells and primes for cutaneous inflammation. Sci. Transl. Med 14, eabn2263 (2022).","journal-title":"Sci. Transl. Med"},{"key":"44645_CR90","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen, F. et al. 2013 classification criteria for systemic sclerosis: an American college of Rheumatology\/European League against rheumatism collaborative initiative. Ann. Rheum. Dis. 72, 1747\u20131755 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"44645_CR91","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1073\/pnas.1813006116","volume":"116","author":"PS Tsou","year":"2019","unstructured":"Tsou, P. S. et al. Inhibition of EZH2 prevents fibrosis and restores normal angiogenesis in scleroderma. Proc. Natl Acad. Sci. USA 116, 3695\u20133702 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44645-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44645-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,6]],"date-time":"2024-01-06T11:09:43Z","timestamp":1704539383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-023-44645-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,3]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["44645"],"URL":"https:\/\/doi.org\/10.1038\/s41467-023-44645-6","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,3]]},"assertion":[{"value":"27 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.E.G. has received Grant support from Celgene\/BMS, Janssen, Eli Lilly, and Almirall. J.E.G. has served on advisory boards for AstraZeneca, Sanofi, Eli Lilly, Boehringer Ingelheim, Novartis, Janssen, Almirall, BMS. J.M.K. has received Grant support from Q32 Bio, Celgene\/BMS, Ventus Therapeutics, and Janssen. J.M.K. has served on advisory boards for AstraZeneca, Eli Lilly, GlaxoSmithKline, Bristol Myers Squibb, Avion Pharmaceuticals, Provention Bio, Aurinia Pharmaceuticals, Ventus Therapeutics, Vera Therapeutics, and Boehringer Ingelheim. P.W.H. has received effort support from Q32 Bio. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"210"}}